Related Experiment Video
Updated: Feb 11, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Isoprostane in systemic sclerosis: A systematic review and meta-analysis
Paul R J Ames1,2, Mira Merashli3, Tommaso Bucci4
1a Immune Response and Vascular Disease Unit , CEDOC, Nova University Lisbon , Lisbon , Portugal.
Systemic sclerosis (SSc) patients show increased isoprostane levels, indicating oxidative stress. Further research is needed to understand the prognostic value of this biomarker in SSc.
Area of Science:
- Biomedical Science
- Clinical Research
- Oxidative Stress Biomarkers
Background:
- Systemic sclerosis (SSc) is characterized by vasculopathy, with oxidative stress implicated as a contributing factor.
- Isoprostanes, derived from arachidonic acid, are recognized markers of oxidative stress and have been linked to vascular dysfunction.
- Understanding the role of isoprostanes in SSc is crucial for advancing knowledge of the disease's pathophysiology.
Purpose of the Study:
- To systematically review and meta-analyze existing studies on isoprostane levels in patients with systemic sclerosis.
- To determine if there is a significant difference in isoprostane levels between SSc patients and healthy controls.
- To explore potential heterogeneity in findings and identify factors influencing isoprostane measurements in SSc.
Main Methods:
- A systematic literature search was conducted in PubMed and EMBASE from January 1990 to December 2017.
- Studies measuring isoprostane levels in systemic sclerosis patients and controls were included, adhering to PRISMA guidelines.
- Random-effect meta-analysis was employed to synthesize data from 8 included studies (240 SSc patients, 192 controls).
Main Results:
- Meta-analysis revealed a significant overgeneration of isoprostanes in SSc patients compared to controls (p < .001), with substantial heterogeneity (I² = 75%).
- Subgroup analysis of urinary isoprostane showed increased excretion in SSc (p = .009, I² = 67%).
- Serum isoprostane analysis indicated overproduction in SSc (p < .0001) with no heterogeneity, though urinary results varied based on measurement units.
Conclusions:
- The findings provide evidence for isoprostane overgeneration in systemic sclerosis, supporting the presence of oxidative stress in the condition.
- Urinary isoprostane levels, particularly when expressed as pmol/mmol creatinine, are elevated in SSc.
- Further prospective studies are warranted to assess the prognostic significance of isoprostane as a biomarker in systemic sclerosis.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

